1. Home
  2. NKGN vs TKLF Comparison

NKGN vs TKLF Comparison

Compare NKGN & TKLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKGN
  • TKLF
  • Stock Information
  • Founded
  • NKGN 2017
  • TKLF 2006
  • Country
  • NKGN United States
  • TKLF Japan
  • Employees
  • NKGN N/A
  • TKLF N/A
  • Industry
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • TKLF Other Specialty Stores
  • Sector
  • NKGN Health Care
  • TKLF Consumer Discretionary
  • Exchange
  • NKGN Nasdaq
  • TKLF Nasdaq
  • Market Cap
  • NKGN 14.1M
  • TKLF 13.9M
  • IPO Year
  • NKGN N/A
  • TKLF 2022
  • Fundamental
  • Price
  • NKGN $0.65
  • TKLF $3.30
  • Analyst Decision
  • NKGN
  • TKLF
  • Analyst Count
  • NKGN 0
  • TKLF 0
  • Target Price
  • NKGN N/A
  • TKLF N/A
  • AVG Volume (30 Days)
  • NKGN 573.8K
  • TKLF 32.0K
  • Earning Date
  • NKGN 12-31-2024
  • TKLF 12-18-2024
  • Dividend Yield
  • NKGN N/A
  • TKLF N/A
  • EPS Growth
  • NKGN N/A
  • TKLF N/A
  • EPS
  • NKGN N/A
  • TKLF 1.70
  • Revenue
  • NKGN N/A
  • TKLF $219,520,631.00
  • Revenue This Year
  • NKGN N/A
  • TKLF N/A
  • Revenue Next Year
  • NKGN N/A
  • TKLF N/A
  • P/E Ratio
  • NKGN N/A
  • TKLF $1.94
  • Revenue Growth
  • NKGN N/A
  • TKLF 32.02
  • 52 Week Low
  • NKGN $0.20
  • TKLF $2.00
  • 52 Week High
  • NKGN $4.06
  • TKLF $9.50
  • Technical
  • Relative Strength Index (RSI)
  • NKGN 65.93
  • TKLF 42.11
  • Support Level
  • NKGN $0.45
  • TKLF $3.14
  • Resistance Level
  • NKGN $0.62
  • TKLF $3.95
  • Average True Range (ATR)
  • NKGN 0.08
  • TKLF 0.32
  • MACD
  • NKGN 0.01
  • TKLF 0.02
  • Stochastic Oscillator
  • NKGN 70.95
  • TKLF 21.35

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores; Online Stores and Services; and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from China followed by Japan and other overseas markets.

Share on Social Networks: